Impact of immunotherapy in populations underrepresented in clinical trials is demonstrated by real-world data.

Published Date: 13 Dec 2023

First-line immunotherapy for advanced non-small cell lung cancer (NSCLC) produced comparable outcomes, according to new research published in the December 2023 issue of the Journal of the National Comprehensive Cancer Network.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Stem Cell Selection Unneeded for SSc Transplant Therapy?

2.

Lung Transplant for Lung Cancer: Promising, in Rare Cases

3.

Rural-urban disparities seen in cervical cancer

4.

Obesity linked to subsequent neoplasms in childhood cancer survivors

5.

New policy review highlights the importance of health-related quality of life in advanced cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot